1. The Impact of Over-The-Counter Lactic Acid Containing Vaginal Gels ...
23 jun 2022 · OTC Vaginal Gels Elicit the Production of Inflammatory Cytokines From Cervicovaginal Epithelial Cells. Heightened vaginal inflammation is ...
The vaginal microbiome influences a wide range of health outcomes in women, where a microbiome dominated by Lactobacillus spp. is considered optimal and associated with reduced risk of pre-term birth and acquisition of sexually transmitted ...
2. Prevention and treatment of gynecological inflammation - Vinmec
Bacterial vaginosis: For this type of vaginitis, your doctor may prescribe metronidazole (Flagyl) that you take by mouth with metronidazole (MetroGel) gel or ...
Vaginitis or vaginitis is an inflammation of the vagina, which can lead to discharge, itching, and pain. The cause of gynecological infections is usually a change in the normal balance of vaginal bacteria or an infection. Decreased estrogen levels after menopause and certain skin disorders can also cause vaginitis.
3. Metronidazole Gel: Uses & Side Effects - Cleveland Clinic
Metronidazole gel is a type of antibiotic that treats bacterial infections in your vagina. It doesn't treat yeast infections or viral infections.
Metronidazole gel is a type of antibiotic that treats bacterial infections in your vagina. It doesn’t treat yeast infections or viral infections.
4. Anti-Candida and Anti-Inflammatory Properties of a Vaginal Gel ... - MDPI
Our results show that RBG impairs C. albicans virulence and is able to reduce the inflammation in the vaginal environment.
Vaginal ecosystem is a unique environment where, in physiological conditions, lactobacilli dominate. However, pathogenic microbial species responsible for vaginitis and vaginosis can also harbor vaginal microbiota. To extend our previously published data, we analyzed here both the anti-Candida and anti-inflammatory properties of the vaginal gel formulation, Respecta® Balance Gel (RBG), commercialized as an adjuvant to treat vaginitis and vaginosis. We evaluated its activity by an in vitro model where a monolayer of A-431 vaginal epithelial cells was infected by Candida albicans in the presence of RBG or the placebo formulation (pRBG). Specifically, we tested the RBG capacity to counteract C. albicans virulence factors and their anti-inflammatory properties. Our results show that, unlike the placebo, RBG reduces C. albicans adhesion, its capacity to form hyphae and C. albicans-induced vaginal cell damage. Interestingly, both RBG and pRBG reduce LPS-induced IL-8 secretion (with RBG being the most effective), demonstrating that also the placebo retains anti-inflammatory properties. From our experimental approach, we highlighted the possible role of farnesol on such effects, but we would like to point out that lactic acid, polydextrose and glycogen too must be relevant in the actual application. In summary, our results show that RBG impairs C. albicans virulence and is able to reduce the inflammation in the vaginal environment, ultimately allowing the establishment of a balanced...
5. Gel for gynecology - IVY Medical Shop
It is spermicide-free, non-greasy and non-staining. · It has an acidic pH and good electrical conductivity. · Soluble in water. · Due to its composition, the gel ...
Gynecology gel 1 piece per 250 ml package
6. Anti-inflammatory gel for gynecology - Eureka | Patsnap
A gynecological and gel technology, which is applied in the direction of anti-inflammatory agents, medical preparations with non-active ingredients, ...
A gynecological and gel technology, which is applied in the direction of anti-inflammatory agents, medical preparations with non-active ingredients, medical raw materials derived from angiosperm subphylum, etc., can solve problems such as iodine stimulation, achieve overcoming the stimulating effect, and significantly anti-inflammatory in gynecology effect of effect
7. Get Gynecological Gel Gynecological Gel Vaginal Inflammation Private ...
Specialized solutions for women's intimate problems and many types of vaginitis.
Top choice for Asian groceries.
8. Antibacterial gel Care for women Green World 5 pcs of applicators
The gel effectively eliminates inflammation, erosion, itching of the vagina, odor, increased yellow-white discharge and other gynecological diseases.
Product Details Antibacterial gel Care for women Green World 5 pcs of applicators - for a woman's intimate hygiene - has antibacterial, anti-inflammatory, regenerative properties, can effectively prevent and promptly solve various types of gynecological inflammation of the vagina Description 5 pcs of applicators - for a woman's intimate hygiene - has antibacterial, anti-inflammatory, regenerative
9. Himalaya V-Gel - Gynaecological gel for intimate infections and irritation
Gynecological Gel - powerful antimicrobial, antibacterial and antifungalHelps in treatment of all Vagina related disease. Helps in the most irritating ...
Gynecological Gel - powerful antimicrobial, antibacterial and antifungalHelps in treatment of all Vagina related disease. Helps in the most irritating issues of women's lives
10. Application of Sol–Gels for Treatment of Gynaecological Conditions ...
Treatment of endometriosis uses various hormonal drugs, including progestins, and GnRH analogues and antagonists, aromatase inhibitors, oestrogen and ...
Approaches for effective and sustained drug delivery to the female reproductive tract (FRT) for treating a range of gynaecological conditions remain limited. The development of versatile delivery platforms, such as soluble gels (sol–gels) coupled with applicators/devices, holds considerable therapeutic potential for gynaecological conditions. Sol–gel systems, which undergo solution-to-gel transition, triggered by physiological conditions such as changes in temperature, pH, or ion composition, offer advantages of both solution- and gel-based drug formulations. Furthermore, they have potential to be used as a suitable drug delivery vehicle for other novel drug formulations, including micro- and nano-particulate systems, enabling the delivery of drug molecules of diverse physicochemical character. We provide an anatomical and physiological perspective of the significant challenges and opportunities in attaining optimal drug delivery to the upper and lower FRT. Discussion then focuses on attributes of sol–gels that can vastly improve the treatment of gynaecological conditions. The review concludes by showcasing recent advances in vaginal formulation design, and proposes novel formulation strategies enabling the infusion of a wide range of therapeutics into sol–gels, paving the way for patient-friendly treatment regimens for acute and chronic FRT-related conditions such as bacterial/viral infection control (e.g., STDs), contraception, hormone replacement therapy (HRT), infertility...
11. Pelvic inflammatory disease - Treatment - NHS
If it's diagnosed early, pelvic inflammatory disease (PID) can be treated easily and effectively with antibiotics prescribed by a GP or doctor in a sexual ...
If it's diagnosed early, pelvic inflammatory disease (PID) can be treated easily and effectively with antibiotics prescribed by a GP or doctor in a sexual health clinic.
12. Medical gynecological gel intimate inflammation antibacterial anti ...
Cofoe, Medical gynecological gel intimate inflammation antibacterial anti-inflammatory odor itching cervical vaginitis 6 / box, Feminine Care, Yamibuy.com.
Medical gynecological gel intimate inflammation antibacterial anti-inflammatory odor itching cervical vaginitis 6 / box, Brand: Cofoe, Feminine Care-Yami. 100% authentic, 30-day return guarantee, authorized retailer, low price.
13. Pelvic inflammatory disease (PID) - Symptoms & causes - Mayo Clinic
Pelvic inflammatory disease: Gynecologic problems FAQ077. American College of Obstetricians and Gynecologists. https://www.acog.org/Patients/FAQs/Pelvic- ...
This serious infection of the female reproductive organs can cause long-term complications such as infertility and chronic pain. Know the symptoms and causes.
14. Drug Treatment of Common STDs: Part II. Vaginal Infections, Pelvic ...
15 okt 1999 · The Centers for Disease Control and Prevention (CDC) released new guidelines for the treatment of sexually transmitted diseases (STDs) in ...
The Centers for Disease Control and Prevention (CDC) released new guidelines for the treatment of sexually transmitted diseases (STDs) in 1998. Several treatment advances have been made since the previous guidelines were published. Part II of this two-part series on STDs describes recommendations for the treatment of diseases characterized by vaginal discharge, pelvic inflammatory disease, epididymitis, human papillomavirus infection, proctitis, proctocolitis, enteritis and ectoparasitic diseases. Single-dose therapies are recommended for the treatment of several of these diseases. A single 1-g dose of oral azithromycin is as effective as a seven-day course of oral doxycycline, 100 mg twice a day, for the treatment of chlamydial infection. Erythromycin and ofloxacin are alternative agents. Four single-dose therapies are now recommended for the management of uncomplicated gonococcal infections, including 400 mg of cefixime, 500 mg of ciprofloxacin, 125 mg of ceftriaxone or 400 mg of ofloxacin. Advances in the treatment of bacterial vaginosis also have been made. A seven-day course of oral metronidazole is still recommended for the treatment of bacterial vaginosis in pregnant women, but intravaginal clindamycin cream and metronidazole gel are now recommended in nonpregnant women. Single-dose therapy with 150 mg of oral fluconazole is a recommended treatment for vulvovaginal candidiasis. Two new topical treatments, podofilox and imiquimod, are available for patient self-administ...
15. Single-Dose, Bioadhesive Clindamycin 2% Gel for Bacterial...
A new, single-dose clindamycin vaginal gel was highly effective, with excellent safety, in women disproportionately affected by bacterial vaginosis.
l vaginosis, that is, all four Amsel's criteria, without other genital infections. Nugent scores of 7–10 were required for efficacy assessment, per updated 2019 U.S. Food and Drug Administration guidance. Patients were evaluated at screening, day 7–14, and day 21–30 (test of cure). Clinical cure was defined as resolution of three of four Amsel's criteria. Bacteriologic cure was defined as Nugent score lower than 4. Therapeutic cure was both clinical and bacteriologic cure. Primary outcome was clinical cure at the test-of-cure visit. Secondary endpoints were clinical cure at day 7–14, and bacteriologic and therapeutic cures at day 7–14 and test of cure. A sample size of 188 patients in the clindamycin group compared with 94 patients in the placebo group had 90% power to detect statistically significant difference (P=.05, 2-tailed). RESULTS: Participants were seen between July 9, 2020, and November 12, 2020. Of 307 randomized women, 56.0% were Black and 88.3% reported one or more previous bacterial vaginosis episodes. In the modified intention-to-treat population, 70.5% of patients in the clindamycin group and 35.6% in the placebo group achieved clinical cure at test of cure (primary outcome) (difference of 34.9, 95% CI 19.0–50.8), as did 77.5% of patients in the clindamycin group and 42.6% of patients in the placebo group in the per-protocol population (difference of 34.9, 95% CI 17.0–52.7). Statistically significant differences between groups were seen for all secondary...
16. Unexpected Inflammatory Effects of Intravaginal Gels (Universal ... - PLOS
In this randomized crossover study, 27 healthy female volunteers used a nightly application of intravaginal nonoxynol-9 (N9) gel as a “failed” microbicide or ...
Intravaginal anti-HIV microbicides could provide women with a self-controlled means for HIV prevention, but results from clinical trials have been largely disappointing. We postulated that unrecognized effects of intravaginal gels on the upper female reproductive tract might contribute to the lower-than-expected efficacy of HIV microbicides. Our objective was to study the effects of intravaginal gels on the immune microenvironment of the cervix and uterus. In this randomized crossover study, 27 healthy female volunteers used a nightly application of intravaginal nonoxynol-9 (N9) gel as a “failed” microbicide or the universal placebo gel (UPG) as a “safe” gel (intervention cycles), or nothing (control cycle) from the end of menses to the mid-luteal phase. At a specific time-point following ovulation, all participants underwent sample collection for measurements of T-cell phenotypes, gene expression, and cytokine/chemokine protein concentrations from 3 anatomic sites above the vagina: the cervical transformation zone, the endocervix and the endometrium. We used hierarchical statistical models to estimate mean (95% CI) intervention effects, for N9 and UPG relative to control. Exposure to N9 gel and UPG generated a common “harm signal” that included transcriptional up-regulation of inflammatory genes chemokine (C-C motif) ligand 20 (macrophage inflammatory factor-3alpha) and interleukin 8 in the cervix, decreased protein concentrations of secretory leukocyte protease inhibitor, a...
17. Pelvic Inflammatory Disease (PID) - STI Treatment Guidelines - CDC
IUDs are one of the most effective contraceptive methods. Copper-containing and levonorgestrel-releasing IUDs are available in the United States.
STI Treatment Guidelines from CDC
18. Pelvic Inflammatory Disease (PID) - MSD Manual Professional Edition
Pelvic inflammatory disease (PID) is a polymicrobial infection of the upper female genital tract: the cervix, uterus, fallopian tubes, and ovaries; abscess may ...
Pelvic Inflammatory Disease (PID) - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the MSD Manuals - Medical Professional Version.
19. Gynecological Inflammatory Gel - Ebeosi
Ebeosi, a leading online wholesale/distribution marketplace in Africa, distributing high quality cosmetics, fashion, groceries, computer accessories, sporting ...
Ebeosi, a leading online wholesale/distribution marketplace in Africa, distributing high quality cosmetics, fashion, groceries, computer accessories, sporting goods, health & beauty, Mobile Accessories, and more at an amazing price.
20. Gynecological Gel Antibacterial Authentic Private Area Maintenance ...
YNBC, Gynecological Gel Antibacterial Authentic Private Area Maintenance Vaginal Inflammation Gynecological Drugs 5 Pieces/box, Feminine Health Solutions, ...
Gynecological Gel Antibacterial Authentic Private Area Maintenance Vaginal Inflammation Gynecological Drugs 5 Pieces/box, Brand: YNBC, Feminine Health Solutions-Yami. 100% authentic, 30-day return guarantee, authorized retailer, low price.
21. Vaginal Irritation And PID (Pelvic Inflammatory Disease)
Visit the London Obs and Gynae Clinic, which offers gynecologic services for women of all ages and treatment for vaginal irritation and pelvic inflammatory ...
Visit the London Obs and Gynae Clinic, which offers gynecologic services for women of all ages and treatment for vaginal irritation and pelvic inflammatory disease.
22. Gynecological Inflammatory Gel( 3 Products ) - Uquid
Gynecological Inflammatory Gel( 3 Products ) ; $45.99 -28% ; $29.31 -18% ; $35.22 -30%.
Uquid, Crypto, Cryptocurrency, Online shopping, Automotive, Phones, Accessories, Computers, Electronics, Fashion, Beauty, Health, Home, Garden, Toys, Sports, Weddings
23. Pelvic inflammatory disease - NHG-Richtlijnen
Pelvic inflammatory disease. NHG-werkgroep: Bouma M, van Dam A, Dekker J, van Kesteren P, Ketel I, Schep-Akkerman ...
PID is een polymicrobiële infectie, die zowel veroorzaakt kan worden door soa’s (Chlamydia trachomatis, Neisseria gonorrhoeae, mogelijk Mycoplasma genitalium) als door bacteriën die horen tot de endogene flora van vagina en cervix, waaronder aerobe, anaerobe en gramnegatieve bacteriën.
24. Pelvic Inflammatory Disease (PID) - MSD Manuals
Less commonly, women are infected during a vaginal delivery, an abortion, or a medical procedure, such as dilation and curettage (D and C) or gynecologic ...
Pelvic Inflammatory Disease (PID) - Learn about the causes, symptoms, diagnosis & treatment from the MSD Manuals - Medical Consumer Version.
